These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Procedures and methods of benefit assessments for medicines in Germany. Bekkering GE, Kleijnen J. Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905 [Abstract] [Full Text] [Related]
24. [Interventions to improve the management of diabetes mellitus in primary health care and outpatient community settings]. Hansen LJ, Drivsholm TB. Ugeskr Laeger; 2002 Jan 28; 164(5):607-9. PubMed ID: 11871208 [Abstract] [Full Text] [Related]
25. A guide to interpreting discordant systematic reviews. Jadad AR, Cook DJ, Browman GP. CMAJ; 1997 May 15; 156(10):1411-6. PubMed ID: 9164400 [Abstract] [Full Text] [Related]
27. A flow diagram to facilitate selection of interventions and research for health care. Irwig L, Zwarenstein M, Zwi A, Chalmers I. Bull World Health Organ; 1998 May 15; 76(1):17-24. PubMed ID: 9615493 [Abstract] [Full Text] [Related]
28. Procedures and methods of benefit assessments for medicines in Germany. Bekkering GE, Kleijnen J. Eur J Health Econ; 2008 Nov 15; 9 Suppl 1():5-29. PubMed ID: 18987905 [Abstract] [Full Text] [Related]
29. [Interventions to improve the management of diabetes mellitus in primary health care and outpatient community settings]. Hansen LJ, Drivsholm TB. Ugeskr Laeger; 2002 Jan 28; 164(5):607-9. PubMed ID: 11871208 [Abstract] [Full Text] [Related]
30. A guide to interpreting discordant systematic reviews. Jadad AR, Cook DJ, Browman GP. CMAJ; 1997 May 15; 156(10):1411-6. PubMed ID: 9164400 [Abstract] [Full Text] [Related]
31. [Procedures and methods of benefit assessments for medicines in Germany]. Bekkering GE, Kleijnen J. Dtsch Med Wochenschr; 2008 Dec 15; 133 Suppl 7():S225-46. PubMed ID: 19034813 [Abstract] [Full Text] [Related]
33. Setting priorities in prevention. Schaapveld K, van de Water HP, Bergsma EW. Health Policy; 1992 Dec 15; 20(3):277-87. PubMed ID: 10118012 [Abstract] [Full Text] [Related]
34. Developing evidence-based clinical practice guidelines: lessons learned by the US Preventive Services Task Force. Woolf SH, DiGuiseppi CG, Atkins D, Kamerow DB. Annu Rev Public Health; 1996 Dec 15; 17():511-38. PubMed ID: 8724238 [Abstract] [Full Text] [Related]
35. Does home visiting prevent childhood injury? A systematic review of randomised controlled trials. Roberts I, Kramer MS, Suissa S. BMJ; 1996 Jan 06; 312(7022):29-33. PubMed ID: 8555855 [Abstract] [Full Text] [Related]
36. Cholesterol lowering and mortality: the importance of considering initial level of risk. Smith GD, Song F, Sheldon TA. BMJ; 1993 May 22; 306(6889):1367-73. PubMed ID: 8518602 [Abstract] [Full Text] [Related]
37. Vitamin A supplementation in infectious diseases: a meta-analysis. Glasziou PP, Mackerras DE. BMJ; 1993 Feb 06; 306(6874):366-70. PubMed ID: 8461682 [Abstract] [Full Text] [Related]
38. How cost-effective is breast cancer screening in different EC countries? van Ineveld BM, van Oortmarssen GJ, de Koning HJ, Boer R, van der Maas PJ. Eur J Cancer; 1993 Feb 06; 29A(12):1663-8. PubMed ID: 8398290 [Abstract] [Full Text] [Related]